Viz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for the Third Consecutive...
Honored for excellence and innovation in cardiovascular health diagnostics for Viz HCM module SAN FRANCISCO – April 4, 2025 –...
Apr 04, 2025
Press & News
Explore our News & Press
Four New Studies Demonstrate that Viz.ai Finds New Patients with Hypertrophic Cardiomyopathy Earlier...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2025 demonstrates positive impact of Viz.ai on...
Mar 26, 2025
Viz.ai Wins Prestigious Prix Galien USA Award for Best Digital Health Solution
Recognition highlights the transformative patient impact of AI-powered care coordination SAN FRANCISCO – November 08, 2024 –Viz.ai, the leader in...
Nov 12, 2024
Viz.ai and Cleerly Partner on Heart Disease Evaluation Using Artificial Intelligence
New partnership delivers critical insights to more cardiovascular care teams to identify and define atherosclerosis earlier SAN FRANCISCO – September...
Sep 04, 2024
Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients
Collaboration aims to accelerate speed to diagnosis and treatment of hypertrophic cardiomyopathy SAN FRANCISCO – June 13, 2024 – Viz.ai,...
Jun 13, 2024
Viz.ai Announces Three New Studies Supporting Viz HCM™ Module for the Detection and...
Real-world evidence at the American College of Cardiology Scientific Session 2024 demonstrates positive impact of Viz.ai on suspected disease detection...
Apr 03, 2024
Viz.ai Announces Expansion into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in...
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment SAN FRANCISCO, CA – September 26, 2023 -...
Sep 26, 2023
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension SAN FRANCISCO, CA – August...
Aug 25, 2023
Viz.ai Receives First De Novo Approval by the FDA for AI Algorithm for...
New artificial intelligence algorithm for earlier detection and management of hypertrophic cardiomyopathy SAN FRANCISCO, CA – August 15, 2023 -...
Aug 15, 2023